Cell & Gene Therapy
-
A Rapid, Scalable Lentiviral Vector Purification Platform
5/15/2026
Integrated capture and polishing reduce upstream impurities, enabling high‑capacity polishing, strong lentiviral recovery, and scalable purity for downstream in vivo applications.
-
Accelerated Yield Optimization Of Affinity Capture
5/15/2026
High‑throughput affinity screening shows how buffer and pH optimization can boost AAV5 recovery, enabling faster, more reliable downstream process development for challenging serotypes.
-
Eliminating Barriers To In Vivo And Ex Vivo CAR-T Delivery
3/17/2026
Learn how lentiviral vector processes evolve for in vivo and ex vivo CAR‑T—covering yield, purity, scalability, and shifting regulatory demands for safe, consistent systemic delivery.
-
Revolutionizing Lentiviral Vector Manufacturing For In Vivo, Ex Vivo CAR-T Therapies
12/29/2025
Discover how scalable, cost-effective, and high-quality lentiviral vector manufacturing can accelerate both ex vivo and emerging in vivo CAR-T therapies.
-
Accelerated LVV Manufacturing Enabled By Platform Excellence
11/25/2025
Discover how a manufacturing platform enabled the rapid production of lentiviral vector in eight months. Learn the strategy used to balance speed, risk mitigation, and the highest quality standards.
-
Green Chemistry: Inherently Safer Chemistry For Accident Prevention
11/12/2025
Chemical manufacturing must prioritize inherently safer substances to prevent accidents. Adopting greener alternatives improves worker health, lowers costs, and leads to safer products.
-
Green Chemistry: Catalysis – Use Catalysts, Not Stoichiometric Reagents
11/12/2025
True green chemistry minimizes waste and maximizes effectiveness. Catalysis is a key technology for reducing the E-factor and increasing efficiency across industrial and biological synthesis.
-
The Principles Of Green Chemistry: Design For Energy Efficiency
11/11/2025
Focusing on solvent management is key to minimizing energy consumption in synthesis. By reducing or replacing solvents, chemists significantly cut both hazardous waste and process energy use.
-
Viral Vector Services
9/18/2025
Fast-track your Gene Therapies from cutting-edge process development to commercial success with advanced viral vector manufacturing solutions!
-
Generation Of A Universal AAV Packaging Cell Line For Commercial Gene Therapy Manufacturing
9/4/2025
Uncover the benefits of this CGMP-ready, stable AAV packaging cell line with proven expertise to reduce costs, streamline manufacturing, and make life-changing gene therapies more accessible to patients in need.